Ylva Böttiger - Concepedia

Author

Ylva Böttiger

Karolinska Institutet ORCID

Also Known As

&NA;, Y BOTTIGER, Y Bottiger, Y Böttiger, Y. BÖTTIGER, Y. Böttiger, Ylva Böttiger

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Karolinska Institutet Karolinska University Hospital Linköping University University of Zagreb Stockholm County Council

About

Ylva Böttiger is an author at Karolinska Institutet specializing in medicine, pharmacology, and health informatics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	16	751
2	Public Health	3	3	183
3	Health Sciences	2	2	46
4	Natural Sciences	1	1	24
5	Nursing	1	1	101

Ylva Böttiger

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
SFINX—a drug-drug interaction database designed for clinical decision support systems Ylva Böttiger, Kari Laine, Marine L. Andersson, European Journal of Clinical Pharmacology Drug InteractionsBiomedical Data IntegrationMedicineDrug Information SystemPersonalized Treatment	2009	155
Cytochrome P450 Induction by Rifampicin in Healthy Subjects: Determination Using the Karolinska Cocktail and the Endogenous CYP3A4 Marker 4β-Hydroxycholesterol Ulf Diczfalusy, Tobias Bäckström, Erik Sparve, Clinical Pharmacology & Therapeutics	2008	131
4β‐Hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half‐life of elimination after induction with rifampicin Ulf Diczfalusy, Kajsa P. Kanebratt, Eva Bredberg, British Journal of Clinical Pharmacology	2008	120
Enantioselective hydroxylation of omeprazole catalyzed by CYP2C19 in Swedish white subjects* Gunnel Tybring, Ylva Böttiger, Jolanta Widén, Clinical Pharmacology & Therapeutics	1997	103
Essential competencies in prescribing: A first european cross‐sectional study among 895 final‐year medical students DJ Brinkman, Jelle Tichelaar, Tim Schutte, Clinical Pharmacology & Therapeutics Adequate Prescribing CompetenciesAllied Health ProfessionsPrimary CareLearning Health SystemsClinical Pharmacy	2016	101
Inhibition of the sulfoxidation of omeprazole by ketoconazole in poor and extensive metabolizers of S-mephenytoin* Ylva Böttiger, Gunnel Tybring, E. Götharson, Clinical Pharmacology & Therapeutics	1997	83
Paediatric drug use with focus on <i>off‐label</i> prescriptions at Swedish hospitals – a nationwide study Elin Kimland, Per Nydert, Viveca Odlind, Acta Paediatrica	2012	82
In vivo interconversion of 7β-hydroxycholesterol and 7-ketocholesterol, potential surrogate markers for oxidative stress Hanna Larsson, Ylva Böttiger, Luigi Iuliano, Free Radical Biology and Medicine OxysterolBiochemistryMedicineLipid PeroxidationPotential Surrogate Markers	2007	81
Pharmacokinetic interaction between single oral doses of ditiazem and sirolimus in healthy volunteers*1 Ylva Böttiger Clinical Pharmacology & Therapeutics	2001	75
Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: An interaction study with fluvoxamine and ketoconazole as in vivo inhibitors* Eva Arlander, Gunilla Ekström, Christina Alm, Clinical Pharmacology & Therapeutics	1998	72

Page 1